Zeo ScientifiX (ZEOX) EPS (Basic) Growth (1y) (2013 - 2026)
Powered by 
Analysis
Zeo ScientifiX (ZEOX) EPS (Basic) Growth (1y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 39.88% |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 68.53% |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 162.14% |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | -102.31% |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 515.34% |
| 10 | Zeo ScientifiX | 9.03 Mn | 7.19 Mn | 2.06 Mn | 69.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 69.77% |
| Jan 31, 2026 | 37.07% |
| Oct 31, 2025 | 52.18% |
| Jul 31, 2025 | -71.83% |
| Apr 30, 2025 | 13.08% |
| Jan 31, 2025 | -4.63% |
| Oct 31, 2024 | -21.41% |
| Jul 31, 2024 | -16,605.69% |
| Apr 30, 2024 | -18,338.50% |
| Jan 31, 2024 | -11,674.83% |
| Oct 31, 2023 | -6,986.93% |
| Jul 31, 2023 | 54.61% |
| Apr 30, 2023 | -3.02% |
| Jan 31, 2023 | -2.01% |
| Oct 31, 2022 | -193.47% |
| Jul 31, 2022 | -85.29% |
| Apr 30, 2022 | 36.49% |
| Jan 31, 2022 | 81.04% |
| Oct 31, 2021 | 88.25% |
| Jul 31, 2021 | 81.07% |